Literature DB >> 10642685

Vascular tumors and vascular malformations: evidence for an association.

M C Garzon1, O Enjolras, I J Frieden.   

Abstract

BACKGROUND: The International Society for the Study of Vascular Anomalies classification is an updated biologic classification that distinguishes vascular tumors from vascular malformations on the basis of clinical and histologic characteristics and biologic behavior.
OBJECTIVE: We propose that in a minority of cases there is an association between vascular tumors and vascular malformations.
METHODS: We retrospectively identified clinical cases in our medical centers and others reported in the medical literature that demonstrate an association between vascular tumors and vascular malformation clinically or histologically.
RESULTS: We identified several clinical or histologic settings in which vascular tumors and vascular malformations were associated: (1) coexistence of hemangioma and vascular malformation at the same anatomic site or in close proximity; (2) pyogenic granuloma arising within a vascular malformation; (3) hemangioma associated with developmental vascular anomalies; (4) spindle-cell hemangioendothelioma and venous malformation; (5) kaposiform hemangioendothelioma and lymphatic malformation.
CONCLUSION: The biologic classification of vascular birthmarks distinguishing vascular tumors from vascular malformations is clinically useful and forms the framework for our understanding of vascular anomalies. These examples suggest that in a small minority of patients there is an association between vascular tumors and vascular malformations.

Entities:  

Mesh:

Year:  2000        PMID: 10642685     DOI: 10.1016/S0190-9622(00)90138-5

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  9 in total

1.  The use of Onyx for embolization of peripheral vascular malformations in pediatric patients.

Authors:  Murat Cantasdemir; Fatih Gulsen; Serdar Solak; Gokce Yalcin Gulsen; Fatih Kantarci; Furuzan Numan
Journal:  Pediatr Surg Int       Date:  2012-01-22       Impact factor: 1.827

2.  Histopathological reporting of paediatric cutaneous vascular anomalies in relation to proposed multidisciplinary classification system.

Authors:  M Al-Adnani; S Williams; D Rampling; M Ashworth; M Malone; N J Sebire
Journal:  J Clin Pathol       Date:  2006-06-02       Impact factor: 3.411

3.  Multidetector CT angiography of pediatric vascular malformations and hemangiomas: utility of 3-D reformatting in differential diagnosis.

Authors:  Mark A Bittles; Manrita K Sidhu; Raymond W Sze; Laura S Finn; Victor Ghioni; Johnathan A Perkins
Journal:  Pediatr Radiol       Date:  2005-07-23

Review 4.  New Frontiers in Our Understanding of Lymphatic Malformations of the Head and Neck: Natural History and Basic Research.

Authors:  Jonathan A Perkins
Journal:  Otolaryngol Clin North Am       Date:  2018-02       Impact factor: 3.346

Review 5.  Classification and imaging of vascular malformations in children.

Authors:  Laurence J Abernethy
Journal:  Eur Radiol       Date:  2002-12-12       Impact factor: 5.315

6.  Hemangiomas in children: challenges and outcome of surgical management in benin city, Nigeria.

Authors:  Osarumwense David Osifo; Iyekoretin Evbuomwan
Journal:  Iran J Pediatr       Date:  2011-09       Impact factor: 0.364

7.  Capillary hemangioma in maxillary anterior region: a case report.

Authors:  V Satish; Manohar Bhat; Prabhadevi C Maganur; Parth Shah; Vijay Biradar
Journal:  Int J Clin Pediatr Dent       Date:  2014-08-29

8.  Hemangioma of the buccal fat pad.

Authors:  Ali Hassani; Sarang Saadat; Roya Moshiri; Solaleh Shahmirzadi
Journal:  Contemp Clin Dent       Date:  2014-04

9.  Consequences of Facial Hemangioma with Regard to Dental Treatment.

Authors:  Gabriela Cristina Santin; Késsia Suênia Fidelis de Mesquita Guimarães; Sara Silva de Oliveira; Raquel Assed Bezerra da Silva; Paulo Nelson-Filho; Regina Guenka Palma-Dibb; Alexandra Mussolino de Queiroz
Journal:  Contemp Clin Dent       Date:  2017 Jan-Mar
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.